Hepatitis B Foundation

BOARD OFFICERS

Chairman
Joel Rosen, Esq.

President
Timothy M. Block, Ph.D.

Vice President
W. Thomas London, MD

Treasurer
R. Donald Leedy, MBA

Secretary
Janine Witte

BOARD OF DIRECTORS

Joan M. Block, RN, BSN
Co-Founder and Executive Director
Hepatitis B Foundation

Thomas Block
President and CEO
Naked Chocolate Café

Timothy M. Block, Ph.D.
Co-Founder, Hepatitis B Foundation
Professor and Director, Drexel Institute for Biotechnology and Virology Research of Drexel University College of Medicine

Stanley Broadbent
Sr. Vice-President/Director of Sales
Glenmede Trust Co.

Alan Brownstein, MPH
Executive Director
National Alliance for Thrombosis and Thrombophilia

Sandra Budinsky
Consultant
Coaching Solutions

James Datin
Executive Vice President, Life Sciences Group
Safeguard Scientifics

Kimberley Jungkind, MPH, RN, CCM
Director, Customer Development
Strategic Initiatives
Corporate & Government Customers
Pfizer

Dale Kindregan
Vice President, Endowments & Foundations
AIG Investments

R. Donald Leedy, MBA
Executive Director
Alliance of Dedicated Cancer Centers

W. Thomas London, MD
Senior Member, IRB Chair
Fox Chase Cancer Center

Joel Rosen, Esq.
Senior Partner
High Swartz Roberts & Seidel

Charles Sigety, Esq.
Retired Business Executive

Gurney P. Sloan, Jr., Esq.
Retired Rohrer Pharma Executive

Catherine Williams, MGA

Janine Witte
Co-Founder, Hepatitis B Foundation
President, Originetics

Robert Zivin, Ph.D.
Senior Director, Corporate Office of Science & Technology
Johnson & Johnson

 

MEDICAL AND SCIENTIFIC ADVISORS

Harvey Alter, MD, Chief, Infectious Disease Section, Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD

Timothy M. Block, Ph.D., Professor and Director, Drexel Institute for Biotechnology and Virology Research of Drexel University College of Medicine, Philadelphia, PA

Baruch Blumberg, MD, Ph.D., Nobel laureate and Senior Member, Fox Chase Cancer Center, Phila, PA; Distinguished Scholar, Hepatitis B Foundation

Nathaniel Brown, MD, Senior Vice President, Clinical Development, Presidio Pharmaceuticals, San Francisco, CA

Carol Brosgart, MD, Independent Medical Consultant; retired executive from the pharmaceutical industry

Raymond Dwek, D.Phil., FRS, Professor, University of Oxford and Founder, Glycobiology Institute at Oxford University, Oxford, UK

Lawrence Friedman, MD, Chair, Dept. of Medicine, Newton-Wellesley Hospital

Robert Gish, MD, Medical Director, Liver Transplant Program, California Pacific Medical Center, San Francisco, CA

Hie-Won L. Hann, MD, Professor and Director, Liver Disease Prevention Center, Thomas Jefferson University Hospital, Philadelphia, PA

W. Thomas London, MD, Senior Member, IRB Chair, Fox Chase Cancer Center, Philadelphia, PA

William Mason, Ph.D., Senior Member, Fox Chase Cancer Center, Philadelphia, PA

Brian McMahon, MD, Scientific and Clinical Director, Liver Disease and Hepatitis Program, Alaska Native Medical Center, Fairbanks, AK

Kenneth Rothstein, MD, Chair, Division of Gastroenterology and Hepatology Drexel University College of Medicine, Philadelphia, PA

Raymond Schinazi, Ph.D., Professor, Pediatrics and Chemistry, and Director of the Laboratory of Biochemical Pharmacology, Emory University, Atlanta, GA; Founder of RFS Pharma

Bud Tennant, DVM, James Law Professor, College of Veterinary Medicine, Cornell University, Ithaca, NY

SENIOR MANAGEMENT

Joan Block, RN, BSN
Co-Founder and Executive Director

Margaret Farley
Director of Programs

Patricia McAloon, MBA
Director of Accounting / Finance

• Dr. Baruch Blumberg
• Board of Directors
• Medical and Scientific Advisors